These effects seem to be mediated mainly by the activation of TRPV-1, 5HT-1A, and the allosteric modulation of CB1, showing great therapeutic promise in the management of osteoarthritis and chronic pain. The gene discussed is CNR1; the disease is osteoarthritis.